Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey [Corrigendum]

Samankaltaisia teoksia

• Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey
  Tekijä: Ponzetti, Clemente, et al.
  Julkaistu: (2016)
• A Canadian perspective on the subcutaneous administration of rituximab in non-Hodgkin lymphoma
  Tekijä: MacDonald, D., et al.
  Julkaistu: (2017)
• Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
  Tekijä: Delgado Sánchez, Olga, et al.
  Julkaistu: (2019)
• Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab
  Tekijä: Theodore-Oklota C, et al.
  Julkaistu: (2016-09-01)
• Validation of a treatment satisfaction questionnaire in non-Hodgkin lymphoma: assessing the change from intravenous to subcutaneous administration of rituximab
  Tekijä: Theodore-Oklota, Christina, et al.
  Julkaistu: (2016)